The tariff classification of Paclitaxel (CAS-33069-62-4), in bulk form, from India; Cisapride (CAS-81098-60-4), in bulk form, from India; and Naproxen Sodium (CAS-26159-34-2), in bulk form, from England
Issued December 13, 1996 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 2918.90.3000, 2933.39.4100, 2932.99.6000
Product description
The first product, Paclitaxel, is a natural product with antitumor activity. It is used as an antineoplastic drug. The second product, Cisapride, is a peristaltic stimulant which is used to reduce the symptoms of nocturnal heartburn associated with gastroesophageal reflux disease. The third product, Naproxen Sodium, is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. With respect to Loratidine, please be advised that your request for a tariff classification ruling is being forwarded to the Office of Regulations and Rulings, U.S. Customs Service Headquarters, Franklin Court, 1301 Constitution Ave., NW, Washington, DC 20029, for their review. A ruling will be issued to you from that office
Full text
NY A89994 December 13, 1996 CLA-2-29:RR:NC:2:238 A89994 CATEGORY: Classification TARIFF NO.: 2932.99.6000; 2933.39.4100; 2918.90.3000 Mr. Michael Tartaro Byron Chemical Company, Inc. 40-11 23rd Street Long Island City, NY 11101 RE: The tariff classification of Paclitaxel (CAS-33069-62-4), in bulk form, from India; Cisapride (CAS-81098-60-4), in bulk form, from India; and Naproxen Sodium (CAS-26159-34-2), in bulk form, from England Dear Mr. Tartaro: In your letter dated November 26, 1996, you requested a tariff classification ruling. The first product, Paclitaxel, is a natural product with antitumor activity. It is used as an antineoplastic drug. The second product, Cisapride, is a peristaltic stimulant which is used to reduce the symptoms of nocturnal heartburn associated with gastroesophageal reflux disease. The third product, Naproxen Sodium, is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. With respect to Loratidine, please be advised that your request for a tariff classification ruling is being forwarded to the Office of Regulations and Rulings, U.S. Customs Service Headquarters, Franklin Court, 1301 Constitution Ave., NW, Washington, DC 20029, for their review. A ruling will be issued to you from that office The applicable subheading for Paclitaxel, imported in bulk form, will be 2932.99.6000, Harmonized Tariff Schedule of the United States (HTS), which provides for: "Heterocyclic compounds with oxygen hetero-atom(s) only: Other: Other: Aromatic: Other: Products described in additional U.S. note 3 to section VI." Pursuant to General Note 13, HTS, the rate of duty will be free. The applicable subheading for Cisapride, imported in bulk form, will be 2933.39.4100, HTS, which provides for: "Heterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: Other: Other: Drugs: Other." Pursuant to General Note 13, HTS, the rate of duty will be free. The applicable subheading for Naproxen Sodium, imported in bulk form, will be 2918.90.3000, HTS, which provides for: "Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulfonated, nitrated or nitrosated derivatives: Other: Aromatic: Other: Drugs." Pursuant to General Note 13, HTS, the rate of duty will be free. This merchandise may be subject to the requirements of the Federal Food, Drug, and Cosmetic Act, which is administered by the U.S. Food and Drug Administration. You may contact them at 5600 Fishers Lane, Rockville, Maryland 20857, telephone number (301) 443-6553. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Cornelius Reilly at 212-466-5770. Sincerely, Roger J. Silvestri Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Roflumilast (CAS No. 162401-32-3), imported in bulk form, from Mexico
The tariff classification of Vilanterol Trifenatate (CAS No. 503070-58-4) in bulk powder form and Umeclidinium Bromide (CAS No. 869113-09-7) in bulk powder form, from India
The tariff classification of Omeprazole (CAS No. 73590-58-6) in bulk powder form, from Croatia
The tariff classification of Revefenacin (CAS No. 864750-70-9) in bulk form, from France
The tariff classification of Maropitant Citrate Monohydrate (CAS No. 359875-09-5) in bulk power form, from Italy
The tariff classification of Maropitant (CAS No. 147116-67-4) in bulk powder form, from Italy
The tariff classification of Difelikefalin Acetate (CAS No. 1024829-44-4) in bulk form, from Taiwan
The tariff classification of Tolperisone Hydrochloride (CAS No. 3644-61-9) in bulk form, from Mexico and Austria
The tariff classification of Brompheniramine Maleate (CAS No. 980-71-2) in bulk form, from India
The tariff classification of Pyrilamine Maleate (CAS No. 59-33-6) in bulk form, from India
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →